1Moutain CF.Revisions in the international system for staging lung cancer.Chest,1997,111:1710～1717.
2Kao YR,Shih JY,Wen WC,et al.Tumor-associated Antigen L6 and the invasion of human lung cancer cells.Clin Cancer Res,2003,9:2807～2816.
3Maruyama R,Sugio K,Mitsudomi T,et al.Relationship between early recurrence and micrometastases in the lymphnodes of patients with stage I non-small-cell lung cancer.J Thorac Cardiovasc Surg,1997,114:535～543.
4Ghazizadeh M,Kagawa S,Oguro T,et al.Tissue polypeptide antigen expression in human prostate tumors.J Cancer Res Clin Oncol,1989,115(1):84～88.
5Ikeda N, Miyoshi Y,Motomura K,et al.Prognostic significance of occult bone marrow micrometastases of breast cancer detected by quantitative polymerase chain reaction for cytokeratin 19 mRNA.Jpn J Cancer Res,2000,91(9):918～924.
6Salerno CT,Frizelle S,Niehans GA,et al.Detection of occult micrometastases in non-small cell lung by reverse transcrep-polymerase Chain Reaction.Chest,1998,113:1526～1532.
7Pilling AM,Mifsud NA,Jones SA,et al.Expression of surfactant protein mRNA in normal and neoplastic lung of B6C3F1 mice as demonstrated by in situ hybridization.Vet Pathol,1999,36:57～63.
8Maruyama R,Sugio K,Fukuyama Y,et al.Evaluation of p53 alterations in occult lymph node metastases.J Surg Oncol,2000,73(3):143～147.
9Marcia V.Fournier,Fernanda C.Guimaraes,Marcos E,et al.Identification of a gene encoding a human oxysterol-binding protein-homologue:a potential general molecular marker for blood dissemination of solid tumors.Cancer Res,1999,59:3748～3753.
10Iwao K,Watanabe T,Fujiwara Y,et al.Isolation of a novel human lung-specific gene,LUNX,a potential molecular marker for detection of micrometastasis in non-small-cell lung cancer.Int J Cancer,2001,91(4):433～437.
5D'Cunha J,Corfits AL,Herndon JE 2nd,et al. Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micro-metastatic tumor cell burden in stage I non-small cell lung cancer-preliminary results of cancer and leukemia group B Trial 9761 [ J ]. J Thorac Cardiovasc Surg ,2002,123 ( 3 ) :484 -491.
6Toyota M, Ho C, Ahuja N, et al. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification[ J ]. Cancer Res, 1999,59 ( 10 ) :2307 - 2312.
7Weidner N, Semple JP, Welch WR, et al. Tumor angiogenesis and metastasis correlation in invasive breast carcinoma [ J ]. N Engl J Med,1991,324(1) :1 -8.
8Folkman J. Tumor angiogenesis: therapeutic implications [ J ]. N Engl J Med, 1971,285 (21) : 1182 - 1186.
9Giatromanolaki A, Koukourakis MI, Theodossiou D, et al. Comparative evaluation of angiogenesis assessment with anti-factor- Ⅷ and anti-CD31 immunostaining in non-small cell lung cancer [J]. Clin Cancer Res,1997 ,3 (12 Pt 1) :2485 -2492.
10Sandler AB,Gray R,Brahmer J,et al.A randomized phase Ⅲ trial comparing bevacizumab/carboplatin/paclitaxel versus carboplatin/paclitaxel in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer(NSCLC)[J].Proc Am Soc Clin Oncol.2005,23:621s.
